
DiSPAH is an AI tool that uses data from patient follow-up studies to estimate the speed of disease progression and identify patterns of muscle decline.
Image Credit: Kano Okada, Nagoya University
Scientific Frontline: Extended "At a Glance" Summary: AI Prediction of ALS Progression (DiSPAH)
The Core Concept: DiSPAH is a machine learning tool developed by researchers at Nagoya University that analyzes patient data to estimate the speed of Amyotrophic Lateral Sclerosis (ALS) progression and identify specific patterns of muscle decline.
Key Distinction/Mechanism: Unlike previous predictive models, DiSPAH simultaneously and independently measures two variables in limb-onset ALS patients: how fast the disease advances and the exact sequence in which physical functions become impaired.
Major Frameworks/Components:
- Pattern Recognition: Identifies six distinct patterns of disease progression based on initial functional assessments.
- Independent Variable Tracking: Separates the speed of decline from the pathway of decline, revealing that severe functional pathways can progress slowly, while milder pathways can progress quickly.
- Genetic Integration: Incorporates genetic markers, such as the C9orf72 gene mutation, which is linked to cellular stress, protein mismanagement, and faster disease progression.

.png)
.png)







.png)
.png)

